Morgan Stanley Initiates Diplomat Pharmacy (DPLO) at Overweight
Tweet
Share
E-mailGet Alerts DPLO Hot Sheet
Price: $4.00 --0%
Rating Summary:
2 Buy, 13 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 10 | New: 17
Rating Summary:
2 Buy, 13 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 10 | New: 17
Join SI Premium – FREE
Morgan Stanley initiated, upgraded coverage on Diplomat Pharmacy (NYSE: DPLO) with an Overweight rating (prior Equal Weight) and a price target of $41.00.
For an analyst ratings summary and ratings history on Diplomat Pharmacy click here. For more ratings news on Diplomat Pharmacy click here.
Shares of Diplomat Pharmacy closed at $34.52 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barclays Upgrades Oscar Health Inc (OSCR) to Overweight, 'we see a visible path to an undemanding 13–15x P/E valuation'
- Cloudflare Inc. (NET) PT Raised to $250 at UBS, Neutral Rating Maintained
- Morgan Stanley Upgrades Western Gas Partners (WES) to Equalweight
Create E-mail Alert Related Categories
New Coverage, UpgradesRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
